Press Releases

Date	Title
4/26/21	Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021
4/22/21	Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021
3/5/21	Pulse Biosciences to Participate in Upcoming Investor Conferences
2/22/21	Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
2/19/21	Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch
2/16/21	Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®
2/12/21	Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021
2/4/21	Pulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
2/3/21	Pulse Biosciences Announces FDA Clearance for the CellFX® System
1/25/21	Pulse Biosciences Announces CE Mark Approval for CellFX® System

Keyword Search